HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (8) Citing Articles via Google Scholar Google Scholar Articles by Iwamoto, T. Search for Related Content PubMed PubMed Citation Articles by Iwamoto, T.

INVITED REVIEW

CALL FOR PAPERS
Molecular Mechanisms Linking Salt to Hypertension

Vascular Na⁺/Ca²⁺ exchanger: implications for the pathogenesis and therapy of salt-dependent hypertension

Department of Pharmacology, School of Medicine, Fukuoka University, Fukuoka, Japan

The Na⁺/Ca²⁺ exchanger is an ion transporter that exchanges Na⁺ and Ca²⁺ in either Ca²⁺ efflux or Ca²⁺ influx mode, depending on membrane potential and transmembrane ion gradients. In arterial smooth muscle cells, the Na⁺/Ca²⁺ exchanger is thought to participate in the maintenance of vascular tone by regulating cytosolic Ca²⁺ concentration. Recent pharmacological and genetic engineering studies have revealed that the Ca²⁺ influx mode of vascular Na⁺/Ca²⁺ exchanger type-1 (NCX1) is involved in the pathogenesis of salt-dependent hypertension. SEA0400, a specific Na⁺/Ca²⁺ exchange inhibitor that preferentially blocks the Ca²⁺ influx mode, lowers arterial blood pressure in salt-dependent hypertensive models, but not in normotensive rats or other types of hypertensive rats. Furthermore, heterozygous mice with reduced expression of NCX1 are resistant to development of salt-dependent hypertension, whereas transgenic mice with vascular smooth muscle-specific overexpression of NCX1 readily develop hypertension after high-salt loading. SEA0400 reverses the cytosolic Ca²⁺ elevation and vasoconstriction induced by nanomolar ouabain, as well as humoral factors in salt-loaded animals. One possibility is that circulating endogenous cardiotonic steroids may be necessary for NCX1-mediated hypertension. These findings help to explain how arterial smooth muscle cells in blood vessels contribute to salt-elicited blood pressure elevation and suggest that NCX1 inhibitors might be therapeutically useful for salt-dependent hypertension.

hypertension; salt intake; Na⁺-K⁺-ATPase; vascular smooth muscle

This article has been cited by other articles:

				A. Y. Bagrov, J. I. Shapiro, and O. V. Fedorova Endogenous Cardiotonic Steroids: Physiology, Pharmacology, and Novel Therapeutic Targets Pharmacol. Rev., March 1, 2009; 61(1): 9 - 38. [Abstract] [Full Text] [PDF]

				S. A. Hirota and L. J. Janssen Sodium and asthma: something borrowed, something new? Am J Physiol Lung Cell Mol Physiol, December 1, 2007; 293(6): L1369 - L1373. [Abstract] [Full Text] [PDF]

				S. Hirota and L. J. Janssen Store-refilling involves both L-type calcium channels and reverse-mode sodium calcium exchange in airway smooth muscle Eur. Respir. J., August 1, 2007; 30(2): 269 - 278. [Abstract] [Full Text] [PDF]

				H. J. Adrogue and N. E. Madias Sodium and Potassium in the Pathogenesis of Hypertension N. Engl. J. Med., May 10, 2007; 356(19): 1966 - 1978. [Full Text] [PDF]

				M. P. Blaustein, J. Zhang, L. Chen, and B. P. Hamilton How does salt retention raise blood pressure? Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2006; 290(3): R514 - R523. [Abstract] [Full Text] [PDF]